D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 46.88 CNY -1.62% Market Closed
Market Cap: 19.5B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Dizal Jiangsu Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dizal Jiangsu Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Revenue
ÂĄ91.3m
CAGR 3-Years
49%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Revenue
ÂĄ17.4B
CAGR 3-Years
102%
CAGR 5-Years
68%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Revenue
ÂĄ5.5B
CAGR 3-Years
33%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Revenue
ÂĄ8.3B
CAGR 3-Years
37%
CAGR 5-Years
31%
CAGR 10-Years
27%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Revenue
ÂĄ46.7B
CAGR 3-Years
30%
CAGR 5-Years
42%
CAGR 10-Years
51%
Imeik Technology Development Co Ltd
SZSE:300896
Revenue
ÂĄ2.9B
CAGR 3-Years
59%
CAGR 5-Years
55%
CAGR 10-Years
N/A

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Revenue?
Revenue
91.3m CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Revenue amounts to 91.3m CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
18%

The average annual Revenue growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been 49% over the past three years , 18% over the past five years .

Back to Top